Titan Partners Introduces Equity Research Division
Titan Partners Group has officially launched its new Equity Research Division, positioning itself prominently in the ever-evolving financial landscape. This strategic move aims to provide deeper insights and expertise in the investment market, particularly within the healthcare sector.
Leadership of Dr. Boris Peaker
At the forefront of this initiative is Dr. Boris Peaker, who has been appointed as the Managing Director and Senior Equity Research Analyst. Dr. Peaker is an esteemed figure in healthcare research, having dedicated 17 years to the industry. His vast experience includes a notable previous role as Managing Director at TD Cowen, where he specialized in biotechnology equity research.
Dr. Peaker's Impressive Background
Dr. Peaker’s career has been marked by significant achievements. He has served at various prestigious firms, including Oppenheimer & Co., Cowen & Co., and Rodman & Renshaw, where he built a reputation as a leading biotechnology analyst. His scholarly accomplishments include a Ph.D. in Biophysics from Stanford University, which adds to his credibility and proficiency in the field. Additionally, his undergraduate degree in Physics and Chemistry from the State University of New York further complements his analytical capabilities.
Strategic Vision for Growth
The establishment of the Equity Research Division is more than just a new departmental launch; it signifies a critical step in Titan Partners’ growth strategy. Jason Sands, Co-Founder and Partner at Titan, emphasized the importance of this new venture, stating that it aligns with Titan’s mission to foster fundamentally strong and scientifically compelling narratives in investment.
Commitment to Life Sciences
Ryan Konik, another Co-Founder and Partner, highlighted the exceptional fit that Dr. Peaker brings to Titan, stating that his technical knowledge and sell-side research experience will significantly bolster their research platform in the life sciences arena. This commitment aims to reinforce trust and credibility in the firm's investment offerings.
About Titan Partners Group
Titan Partners Group operates as a boutique investment bank under American Capital Partners, with a specialization in providing tailored financial solutions for emerging growth companies. The firm, headquartered in New York City, offers comprehensive services in investment banking, capital markets advisory, and research. Titan Partners is dedicated to achieving excellence in the middle-market sector by maintaining high standards in securities transactions, which are essential for helping corporate clients realize their strategic objectives.
Contact Information
If you would like more information about Titan Partners Group, you can reach out using the following contact details:
Email: info@titanpartnersgrp.com
Address: 4 World Trade Center, 29th Floor, New York, NY 10007
Phone: (929) 833-1246
Website: www.titanpartnersgrp.com
Frequently Asked Questions
What is the purpose of the new Equity Research Division?
The division aims to enhance insights and expertise within the healthcare investment market.
Who has been appointed to lead the new division?
Dr. Boris Peaker has been appointed as the Managing Director and Senior Equity Research Analyst.
What is Dr. Peaker’s background?
Dr. Peaker has over 17 years of experience in healthcare equity research and has held leadership roles at top firms.
How does this move fit into Titan Partners' growth strategy?
This launch underlines Titan's commitment to building robust, scientifically-backed investment narratives.
What services does Titan Partners Group offer?
Titan provides investment banking, capital markets advisory, and research, aiming to support emerging growth companies.
